Barley and Rice Mixture Effects on Blood Glucose

NCT03387345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2018-01-02

No results posted yet for this study

Summary

The purpose of this research was to investigate 5 different formulations of whole grain barley and refined white rice against a control of white bread on post-prandial glycemic response, as well as self-reported hunger/satiety in a randomized cross-over trial.

Conditions

  • Blood Glucose
  • Dietary Fiber
  • Hunger

Interventions

OTHER

100% steel cut barley

25 g of available carbohydrate was delivered to participants via steel cut Sustagrain barley (Ardent Mills, LLC).

OTHER

100% barley flakes

25 g of available carbohydrate was delivered to participants via Sustagrain barley flakes (Ardent Mills, LLC).

OTHER

50/50 rice-barley mix

25 g of available carbohydrate was delivered to participants via a 50/50 mixture (by weight) of Goya medium grain white rice and steel cut Sustagrain barley (Ardent Mills, LLC).

OTHER

80/20 rice-barley mix

25 g of available carbohydrate was delivered to participants via a 80/20 mixture (by weight) of Goya medium grain white rice and steel cut Sustagrain barley (Ardent Mills, LLC).

OTHER

100% rice

25 g of available carbohydrate was delivered to participants via Goya medium grain white rice

OTHER

white bread

25 g of available carbohydrate was delivered to participants via Sara Lee Classic White Bread (Bimbo Bakeries USA, Inc.)

Sponsors & Collaborators

  • Ardent Mills, LLC

    collaborator UNKNOWN
  • Arizona State University

    lead OTHER

Principal Investigators

  • Corrie M Whisner, PhD · Arizona State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2017-09-04
Completion
2017-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03387345 on ClinicalTrials.gov